FindTrial
Sign In

Testing the effect of the plant aragwadha on the bacteria staphylococcus aureus which is obtained from the swab sample of eczema patients.

In vitro study of Staphylococcus aureus through swab culture and sensitivity by aragwadha patra in sravi vicharchika with reference to atopic dermatitis - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/113030
Enrollment
30
Registered
2026-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified Health Condition 2: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Dr Bhuvana P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed with sravi vicharchika

Exclusion criteria

Exclusion criteria: Other secondary infections Chronic diabetic ulcer and Immunocompromised conditions

Design outcomes

Primary

MeasureTime frame
To observe isolate and identify Staphylococcus aureus in Sravi Vicharchika and to observe the sensitivity of Aragwadha patra against the organismTimepoint: Cross sectional study—

Secondary

MeasureTime frame
To isolate and identify Staphylococcus aureus in sravi vicharchika from the skin lesions through swab cultureTimepoint: Cross sectional study—

Countries

India

Contacts

Public ContactDr Bhuvana P

Government ayurveda medical College, Bengaluru

drranj.ind@gmail.com9900411210

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026